AIDS Activism and the Pharmaceutical Industry
DOI:
https://doi.org/10.55927/cjas.v2i2.9461Keywords:
key words: AIDS, activism, pharmaceutical industry, HIV/AIDS, ACT UP, drug approval, antiretroviral remedy, healthcare policy, public fitness, medicinal drug pricing.Abstract
The intersection of AIDS activism and the pharmaceutical industry has been pivotal in remodeling public health responses and treatment accessibility for HIV/AIDS. In the Eighties and Nineteen Nineties, AIDS activists and considerable organizations like ACT UP played an essential role in the pharmaceutical industry's regulations and practices. these activists demanded quicker drug approval methods, low-cost medicinal drug pricing, and increased transparency in clinical trials. Their advocacy brought about extensive policy adjustments, which included the elevated approval process by using the U.S. Meals and Drug Administration (FDA) and the implementation of the 340B Drug Pricing application, which made medicines less expensive for underserved populations.The activism now not only compelled pharmaceutical industry to lower expenses but additionally stimulated the enterprise's research and improvement priorities, resulting in an extra-targeted attempt at HIV/AIDS remedies. Furthermore, the collaboration among activists, scientists, and healthcare providers fostered an environment conducive to large scientific breakthroughs, inclusive of the improvement of antiretroviral remedies (art), which has converted HIV/AIDS from a deadly disease to a doable, persistent situation.This dynamic interaction between activism and industry highlights the significance of civic engagement in shaping healthcare coverage and advancing scientific research
Downloads
References
Epstein, S. (1996). Impure Science: AIDS, Activism, and the Politics of Knowledge, University of California Press.
FDA. (2020). multiplied approval utility. Retrieved from FDA.gov.
Marcus, A. (2009). Affected person-doctor communique: An evaluation of the literature. Journal of Fitness Verbal Exchange, 14(1), 17–28.
Bastian, H. (2004). The strength of sharing know-how: affected person empowerment. fitness expectancies, 7(4), 276-278.
AIDS Medical Trials Institution. (2020). Community Advisory Boards. Retrieved from actgnetwork.org.
NIH. (2021). Public involvement in NIH research. Retrieved from nih.gov.
Brown, P., & Zavestoski, S. (2004). Social actions in fitness: An advent. Sociology of Health & Contamination, 26(6), 679–694.
Woodwork, D. (2010). Popularity and electricity: organizational photograph and pharmaceutical law on the FDA. Princeton College Press.
Kaiser family basis. (2016). HIV/AIDS coverage reality sheet. Retrieved from kff.org.
Harrington, M. (1997). ACT UP and the FDA. In D. Kirp & R. Bayer (Eds.), AIDS in the Industrialized Democracies: Passions, Politics, and Rules (pp. 55–96),. Rutgers College Press.
Varmus, H. (2009). The art and politics of technology. W. W. Norton & employer.
Kass, N., & Faden, R. (1996). Ethics and Activism: IRBs and the Improvement of the Federal Recommendations on Human Research. IRB: Ethics & Human Research, 18(5), 9–12.
Nunn, A., Dickman, S., Cornwall, A., & Wandeler, G. (2012). The impacts of network mobilization on HIV prevention and care interventions: a meta-analysis. Worldwide Health Motion, five, 1921.
Shilts, R. (1987). The band performed On: Politics, Humans, and the AIDS Epidemic. St. Martin's Press.
Fauci, A. S. (2003). HIV and AIDS: 20 years of generation. Nature treatment, nine (7), 839–843.
Cohen, J. (1994). The global impact of AIDS. Science, 266(5191), 1564–1569.
Friedman-Kien, A. E., & Saltzman, B. R. (1990). Kaposi's Sarcoma and Pneumocystis Carinii Pneumonia in homosexual guys: The Epidemic of an Immunodeficiency Disease A overview. American Journal of Epidemiology, 132(1), 1–9.
CDC. (2001). AIDS Surveillance: United States of America, 1981–2000. MMWR, 50(21), 429–436.
Curran, J. W., Morgan, W. M., Hardy, A. M., Jaffe, H. W., Darrow, W. W., & Dowdle, W. R. (1985). The epidemiology of AIDS: current reputation and future possibilities. technology, 229 (4720), 1352–1357.
Des Jarlais, D. C., & Friedman, S. R. (1988). HIV infection amongst intravenous drug customers: epidemiology and threat discount. AIDS, 2(four), 241-248.
Denning, P., & DiNenno, E. (2010). Groups in Disaster: Is There a Generalized HIV Epidemic in Impoverished City Areas of the United States? CDC.
Patton, C. (1990). Inventing AIDS, Routledge.
Mann, J. M. (1989). AIDS: A Worldwide Pandemic. Western Magazine of drugs, one hundred fifty (2), 123–125
Epstein, S. (1996). Impure Technology: AIDS, Activism, and the Politics of Knowledge, University of California Press.
FDA. (2020). Accelerated Approval Program. Retrieved from FDA.gov.
Shilts, R. (1987). The band performed on politics, human beings, and the AIDS epidemic. St. Martin's Press.
Mann, J. M. (1989). AIDS: A Global Pandemic. Western Journal of Medication, a hundred and fifty(2), 123–125
Carpenter, D. (2010). Popularity and strength: organizational photograph and pharmaceutical regulation at the FDA. Princeton College Press.
Harrington, M. (1997). ACT UP and the FDA. In D. Kirp & R. Bayer (Eds.), AIDS within the Industrialized Democracies: Passions, Politics, and Rules (pp. 55-96). Rutgers College Press.
Cohen, J. (1994). The Worldwide Impact of AIDS. Technology, 266(5191), 1564–1569.
Denning, P., & DiNenno, E. (2010). groups in crisis: Is There a Generalized HIV Epidemic in Impoverished Urban Areas of America? CDC.
literatureMarcus, A. (2009). patient-health practitioner verbal exchange: A overview of the Literature. Magazine of Health Conversation, 14(1), 17–28.
Brown, P., & Zavestoski, S. (2004). Social actions in health: a creation. Sociology of Health & Contamination, 26(6), 679–694.
Varmus, H. (2009). The artwork and politics of science. W. W. Norton & Co..
Bastian, H. (2004). The strength of sharing understanding: affected person empowerment. fitness expectancies, 7(4), 276-278.
Des Jarlais, D. C., & Friedman, S. R. (1988). HIV contamination amongst intravenous drug users: epidemiology and threat discount. AIDS, 2(4), 241-248.
CDC. (2001). AIDS Surveillance—U.S.A., 1981–2000. MMWR, 50(21), 429–436.
Nunn, A., Dickman, S., Cornwall, A., & Wandeler, G. (2012). The effects of community mobilization on HIV prevention and care interventions: a meta-analysis. Global Health Motion, 5, 1921.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rehan Haider, Asghar Mehdi, Geetha Kumari, Zameer Ahmed, Sambreen Zameer
This work is licensed under a Creative Commons Attribution 4.0 International License.
